Variation in risk indicators of cardiovascular disease during the menstrual cycle: An investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 3, 1996, Pages 241-249

  Larsen, L F ^a,d   Andersen, H R ^a   Hansen, A B ^b   Andersen, O ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c ROSKILDE UNIVERSITY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Activated partial thromboplastin time; Antithrombin; Cholesterol; Factor II+VII+X; Factor VII; Fibrinogen; HDL; LDL; Plasminogen activator inhibitor; Platelet; Tissue plasminogen activator; Triglyceride

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; FIBRINOGEN; GLUTATHIONE PEROXIDASE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARACETAMOL; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG USE; ERYTHROCYTE; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; MALE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; GLUTATHIONE PEROXIDASE; HEMOSTASIS; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MENSTRUAL CYCLE; PLATELET COUNT; RISK;

EID: 0029894928     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609088613     Document Type: Article

References (30)

1. Ciavatti M, Renaud S. Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk. Free Radical Biol Med 1991; 10: 325-8.
2. Gevers-Leuven JA, Kluft C, Bertina RM, Hessel LW. Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems. J Lab Clin Med 1987; 6: 631-6.
3. Jespersen J, Petsersen KR, Skouby SO. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid. Am J Obstet Gynecol 1990; 163: 396-403.
4. Seed M. Sex hormones, lipoproteins and cardiovascular risk. Atherosclerosis 1991; 90: 1-7.
5. Karpanou EA, Vyssoulis GP, Georgoudi DG, Toutouza MG, Toutouza PK. Disparate serum lipids changes between normotensive and hypertensive women during the menstrual cycle. Am J Cardiol 1992; 70: 111-13.
6. De Leon RG, Austin KL, Richards L, Guerrero F. Lipid and hormonal profile of Panamanian women during the menstrual cycle. Int J Gynaecol Obstet 1992; 39: 219-26.
7. Kim H-J, Kalkhoff RK. Changes in lipoprotein composition during the menstrual cycle. Metabolism 1979; 28: 663-8.
8. Basdevant A, de Ligniers B, Bigorie B, Guy-Grand B. Estradiol, progesterone and plasma lipids during the menstrual cycle. Diabetes et Metabolisme 1981; 7: 1-4.
9. Larsson H, Persson S, Hedner P, Odeberg H, Gustafson A. Studies on blood viscosity during the menstrual cycle and in the postmenopausal period in healthy women. Acta Obstet Gynecol Scand 1989; 68: 483-6.
10. Lebech AM, Kjær A. Lipid metabolism and coagulation during the normal menstrual cycle. Horm Metab Res 1989; 21: 445-8.
11. Lebech AM, Kjær A, Lebech PE. Metabolic changes during the normal menstrual cycle: a longitudinal study. Am J Obstet Gynecol 1990; 163: 414-16.
12. Ygge J. Variation in the individual subject of some parameters in blood coagulation and fibrinolysis. Scand J Haematol 1969; 6: 343-7.
13. Cederblad G, Hahn L, Korsan-Bengtsen K, Pehrsson NG, Rybo G. Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle. Haemostasis 1977; 6: 294-302.
14. Jespersen J, Ingeberg S, Bach E. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen. Gynecol Obstet Invest 1983; 15: 153-62.
15. Jespersen J, Kluft C. Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycle. Thromb Haemost 1986; 55: 388-9.
16. Siegbahn A, Odlind V, Hedner U, Venge P. Coagulation and fibrinolysis during the normal menstrual cycle. Uppsala J Med Sci 1989; 94: 137-52.
17. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
18. Beutler E. Red cell metabolism. A manual of biochemical methods. 3rd ed. 1984.
19. Landgren BM, Unden AL, Diczfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol 1980; 94: 89-98.
20. Capel ID, Jenner M, Williams DC, Donaldson D, Nath A. The effect of prolonged oral contraceptive steriode use on erythrocyte glutathione peroxidase activity. J Steroid Biochem 1981; 14: 729-32.
21. Michäelsson G, Edqvist L. Erythrocyte glutathione peroxidase activity in acne vulgaris and the effect of selenium and vitamin E treatment. Acta Dermatol Venereol Stockh 1984; 64: 9-14.
22. Refn H, Kjær A, Lebech A, Borggaard B, Schierup L, Bremmelgaard A. Metabolic changes during treatment with two different progestogens. Am J Obstet Gynecol 1990; 163: 374-7.
23. Lobo RA. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 1990; 75(4): 18S-25S.
24. Jern C, Manhem K, Eriksson E, Tengborn L, Risberg B, Jern S. Haemostatic responses to mental stress during the menstrual cycle. Thromb Haemost 1991; 66: 614-18.
25. Kim I, Yetley EA, Calvo MS. Variations in iron-status measures during the menstrual cycle. Am J Clin Nutr 1993; 58: 705-9.
26. Cullinane EM, Yurgalevitch SM, Saritelli AL, Herbert PN, Thompson PD. Variations in plasma volume affect total and low-density lipoprotein cholesterol during the menstrual cycle. Metabolism 1995; 44: 965-71.
27. Pliner P, Fleming AS. Food intake, body weight and sweetness preference over the menstrual cycle. Physiol Behav 1983; 3: 663-6.
28. Tangney C, Brownie C, Wu S. Impact of menstrual periodicity on serum lipid levels and estimates of dietary intake. J Am Coll Nutr 1991; 10: 107-13.
29. Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in the diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-33.
30. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, et al. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary composition. Atherosclerosis 1991; 86: 163-71.